Kennedy Capital Management, Inc. Nuvasive Inc Transaction History

Kennedy Capital Management, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$36.71 - $44.15 $3.5 Million - $4.22 Million	95,477 Added 56.16%	265,495 $11 Million
Q1 2023 May 15, 2023	SELL	$36.81 - $48.12 $336,921 - $440,442	-9,153 Reduced 5.11%	170,018 $7.02 Million
Q4 2022 Feb 14, 2023	SELL	$35.68 - $44.71 $36,143 - $45,291	-1,013 Reduced 0.56%	179,171 $7.39 Million
Q3 2022 Nov 14, 2022	BUY	$42.51 - $54.02 $5.37 Million - $6.83 Million	126,392 Added 234.96%	180,184 $7.89 Million
Q2 2022 Aug 10, 2022	BUY	$46.84 - $59.75 $124,172 - $158,397	2,651 Added 5.18%	53,792 $2.64 Million
Q1 2022 May 16, 2022	SELL	$48.09 - $57.79 $24,525 - $29,472	-510 Reduced 0.99%	51,141 $2.9 Million
Q4 2021 Feb 14, 2022	SELL	$47.19 - $62.68 $85,461 - $113,513	-1,811 Reduced 3.39%	51,651 $2.71 Million
Q3 2021 Nov 15, 2021	BUY	$56.91 - $67.81 $36,593 - $43,601	643 Added 1.22%	53,462 $3.2 Million
Q2 2021 Aug 16, 2021	SELL	$64.02 - $71.72 $7.88 Million - $8.83 Million	-123,147 Reduced 69.98%	52,819 $3.58 Million
Q1 2021 May 14, 2021	BUY	$53.26 - $68.08 $358,120 - $457,769	6,724 Added 3.97%	175,966 $11.5 Million
Q4 2020 Feb 12, 2021	BUY	$43.41 - $56.51 $7.35 Million - $9.56 Million	169,242 New	169,242 $9.53 Million

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Kennedy Capital Management, Inc. with notifications on news.